Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amarin Corp Ads (AMRN)

6.99   -0.06 (-0.85%) 08-07 14:46
Open: 7 Pre. Close: 7.05
High: 7.37 Low: 6.95
Volume: 6,043,375 Market Cap: 2,695M
Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.185 - 7.219 7.219 - 7.251
Low: 6.745 - 6.783 6.783 - 6.819
Close: 6.986 - 7.047 7.047 - 7.104

Technical analysis

as of: 2020-08-07 2:23:55 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 8.61     One year: 10.05
Support: Support1: 6.71    Support2: 6.30
Resistance: Resistance1: 7.37    Resistance2: 8.61
Pivot: 6.69
Moving Average: MA(5): 6.94     MA(20): 6.69
MA(100): 7.27     MA(250): 13.60
MACD: MACD(12,26): 0.02     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 62.89     %D(3): 62.80
RSI: RSI(14): 56.31
52-week: High: 26.12  Low: 3.95  Change(%): -49.5
Average Vol(K): 3-Month: 636206  10-Days: 623974

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AMRN has closed below upper band by 11.5%. Bollinger Bands are 75.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 76 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 05 Aug 2020
Amarin: Improving HCP Access Should Drive More Vascepa Sales, Says Analyst - Nasdaq

Tue, 16 Jun 2020
Amarin Announces Patent Litigation Settlement Agreement with Apotex Inc. - GlobeNewswire

Tue, 09 Jun 2020
Why Amarin (AMRN) Stock Might be a Great Pick - Yahoo Finance

Tue, 05 May 2020
Amarin (AMRN) Stock Could Stage a Rebound to $15, Says Analyst - Yahoo Finance

Wed, 29 Apr 2020
Is a Beat in Store for Amarin (AMRN) This Earnings Season? - Yahoo Finance

Mon, 06 Apr 2020
Amarin (AMRN) Will Make Excellent Takeover Target, Says Analyst - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 385
Shares Float (M) 347
% Held by Insiders 0.99
% Held by Institutions 43.74
Shares Short (K) 32,310
Shares Short P. Month (K) 34,120

Stock Financials

EPS -0.060
EPS Est This Year -0.210
EPS Est Next Year -0.060
Book Value (p.s.) 1.560
Profit Margin -3.67
Operating Margin -5.00
Return on Assets (ttm) -2.5
Return on Equity (ttm) -5.2
Qtrly Rev. Growth 111.5
Gross Profit (p.s.) 0.866
Sales Per Share 1.327
EBITDA (p.s.) -0.063
Qtrly Earnings Growth
Operating Cash Flow (M) 33
Levered Free Cash Flow (M) 35

Stock Valuations

PE Ratio -116.81
PEG Ratio
Price to Book value 4.49
Price to Sales 5.28
Price to Cash Flow 82.22

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.